Home » Topics » Disease categories and therapies » Immune

Immune
RSS

La Jolla enrolls patients in phase II/III trial for lupus treatment

Oct. 6, 1998

Ono discloses compounds with high binding affinity for prostanoid EP4 receptors

Oct. 6, 1998

Chiroscience identifies new target for autoimmune disease therapy

Oct. 5, 1998

Merck describes new ascomycin derivatives with improved therapeutic potential

Oct. 5, 1998

3M presents first clinical results for potent new immunomodulator

Oct. 5, 1998

Major pediatric study supports safety and efficacy of pneumococcal vaccine

Oct. 1, 1998

Aviron presents new clinical data for FluMist at ICAAC

Oct. 1, 1998

New study shows that LYMErix can be given according to a flexible dosing schedule

Sep. 30, 1998

Pierre Fabre obtains good results with RSV subunit vaccine in monkey model

Sep. 24, 1998

Cangene signs WinRho distribution agreement for Australia

Sep. 24, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026